Rachel Frank
Investor Relations Speaker
Replay available
Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call
Bicara Therapeutics Inc. (NASDAQ: BCAX) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Claire Mazumdar
Chief Executive Officer
Ryan Cohlhepp
President and Chief Operating Officer
Ivan Hyep
Chief Financial Officer
Tyler Van Bern
Analyst, TD Cal
Rene Benjamin
Analyst, Citizens
Bradley Canino
Analyst, Guggenheim
Zeet Mukherjee
Analyst, U.S. Bancorp BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bicara Therapeutics Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04129-1dea-7c60-bbcc-38d725869c79 Created: 2026-08-27T03:00:10.515Z Duration: 2441.9788 Channels: 1 00:00:00.000 -- 00:00:02.639 Good day and thank you for standing by. 00:00:02.720 -- 00:00:04.560 Welcome to the Bicara Therapeutics 00:00:05.600 -- 00:00:09.120 Second Quarter twenty twenty six Earnings Conference Call. 00:00:09.360 -- 00:00:11.360 At this time, all participants are in a 00:00:11.360 -- 00:00:14.345 listen only mode. After the speakers' presentation, 00:00:14.425 -- 00:00:16.745 there'll be a question and answer session. To 00:00:16.745 -- 00:00:18.985 ask a question during the session, you'll need 00:00:18.985 -- 00:00:20.825 to press 11 on your telephone. 00:00:21.145 -- 00:00:23.145 You will then hear an automated message advising 00:00:23.145 -- 00:00:24.585 your hand is raised. 00:00:24.904 -- 00:00:27.705 To answer your question, please press 11 again. 00:00:28.140 -- 00:00:30.699 Please be advised that today's conference is being 00:00:30.699 -- 00:00:31.500 recorded. 00:00:31.660 -- 00:00:33.100 I would now like to turn the conference 00:00:33.100 -- 00:00:35.739 over to your speaker for today, Rachel Frank. 00:00:35.739 -- 00:00:36.620 Please go ahead. 00:00:40.635 -- 00:00:42.555 Thank you, and good morning, everyone. It's a 00:00:42.555 -- 00:00:44.954 pleasure to welcome you to Bicara Therapeutics second 00:00:44.954 -- 00:00:48.155 quarter twenty twenty six earnings call. Earlier this 00:00:48.155 -- 00:00:50.394 morning, we issued a press release highlighting results 00:00:50.394 -- 00:00:52.555 from the quarter and provided a business update, 00:00:52.730 -- 00:00:56.170 including strategic leadership transitions marking the company's next 00:00:56.170 -- 00:00:57.770 era of ...